治療性隱形眼鏡市場按產品類型、應用、分銷管道和地區分類

2024 年全球治療性隱形眼鏡市場規模估計為 49.1 億美元，預計 2031 年將達到 79 億美元，2024 年至 2031 年的複合年成長率為 7%。

圖。

治療性隱形眼鏡是由眼科保健專家開立的特殊鏡片，用於矯正視力和保持眼睛健康。這些鏡片專門用於治療屈光不正、散光、老花眼和各種眼表疾病。白內障、圓錐角膜、糖尿病視網膜病變等眼科疾病發生率的上升推動了對治療性隱形眼鏡的需求。此外，隱形眼鏡材質的技術進步提供了卓越的舒適度和延長配戴時間的能力，進一步擴大了這些鏡片的應用範圍。然而，一些地區對可用的治療方案缺乏認知，以及專業鏡片的價格高昂，可能會在一定程度上抑制市場的成長。

市場動態：

全球治療性隱形眼鏡市場主要受老年人口不斷成長的推動，老年人容易患上需要治療的眼科疾病。根據世界衛生組織2024年10月預測，到2050年，全球整體65歲或以上人口將超過13億人。此外，與文明病（如糖尿病）的發生率不斷上升，從而導致糖尿病視網膜病變等疾病，這也推動了需求。此外，與傳統鏡片相比，矽膠水凝膠鏡片具有更高的透氧滲透性，可延長配戴時間並提高患者的依從性，從而增加了市場採用率。然而，專用鏡片成本高昂（特別是針對罕見疾病）以及新興經濟體對治療方案缺乏認知，帶來了重大挑戰。此外，隱形眼鏡製造的嚴格監管核准和基礎設施要求也對新進業者構成了挑戰。然而，隨著應用領域的不斷擴大和價格實惠的鏡片的持續研發，預計未來幾年將出現新的商機。

本研究的主要特點

本報告對全球治療性隱形眼鏡市場進行了詳細分析，並展示了預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%），以 2023 年為基準年。

它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球治療性隱形眼鏡市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。

研究中涉及的主要企業包括強生公司、愛爾康、博士倫、庫博光學、曼尼康株式會社、豪雅株式會社、卡爾蔡司公司、依視路陸遜梯卡、SynergEyes 公司、OptiMed 技術公司、Aerie 製藥公司、Eyevance 製藥公司、Ocular Therapeutix 技術公司、Visione-Ctel-Btel-Coerings Xt。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球治療性隱形眼鏡市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過用於分析全球治療性隱形眼鏡市場的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 影響分析
• 主要進展
• 監管情景
• 產品發布/核准
• PEST分析
• PORTER 分析
• 併購情景
• 產業趨勢

4. 全球治療性隱形眼鏡市場（依產品類型），2019 年至 2031 年

• 軟式鏡片
• 硬鏡片
• 專業鏡頭

5. 全球治療性隱形眼鏡市場（依應用分類），2019 年至 2031 年

• 眼科手術後
• 角膜疾病
• 藥物輸送
• 其他

6. 全球治療性隱形眼鏡市場，依通路分類，2019-2031 年

• 零售藥局
• 醫院藥房
• 網路藥局

7. 2019 年至 2031 年全球治療性隱形眼鏡市場（按地區）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭格局

• Johnson & Johnson
• Alcon
• Bausch+Lomb
• CooperVision
• Menicon Co., Ltd.
• Hoya Corporation
• Carl Zeiss AG
• EssilorLuxottica
• SynergEyes, Inc.
• OptiMed Technology, Inc.
• Aerie Pharmaceuticals, Inc.
• Eyevance Pharmaceuticals
• Ocular Therapeutix, Inc.
• Visioneering Technologies, Inc.
• X-Cel Specialty Contacts

第 9 章分析師建議

• 命運之輪
• 分析師觀點
• 一致的機會圖

第10章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

The global therapeutic contact lenses market is estimated to be valued at USD 4.91 Bn in 2024 and is expected to reach USD 7.90 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7% from 2024 to 2031.

Figure. Therapeutic Contact Lenses Market Share (%), By Region 2024

Therapeutic contact lenses are specialized lenses prescribed by eye care professionals to support vision correction and eye health. These lenses are designed to treat refractive errors, astigmatism, presbyopia, and various ocular surface diseases. The rising incidence of ocular disorders such as cataract, keratoconus, and diabetic retinopathy has been driving the demand for therapeutic contact lenses. Additionally, technological advancements in contact lens materials that offer superior comfort and extended wear capabilities are further widening the application scope of these lenses. However, lack of awareness about available treatment options and high cost of specialized lenses in some regions may restrain the market growth to some extent.

Market Dynamics:

The global therapeutic contact lenses market is primarily driven by the growing geriatric population which is more susceptible to ocular diseases requiring treatment. According to the WHO, in October 2024, estimates reveal over 1.3 billion people globally will be aged 65 years or older by 2050. Additionally, rising prevalence of lifestyle diseases such as diabetes propelling conditions like diabetic retinopathy is also fueling the demand. The market is also witnessing increasing adoption of silicone hydrogel lenses owing to their enhanced oxygen permeability compared to conventional lenses, allowing extended wear periods and better patient compliance. However, high cost of specialty lenses particularly for rare conditions and lack of awareness about treatment options in developing economies are major challenges. Moreover, stringent regulatory approvals and infrastructure requirements for contact lenses manufacturing pose difficulties for new entrants. Nevertheless, ongoing R&D to expand applications and develop affordable lenses presents new opportunities in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global therapeutic contact lenses market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global therapeutic contact lenses market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Johnson & Johnson, Alcon, Bausch + Lomb, CooperVision, Menicon Co., Ltd., Hoya Corporation, Carl Zeiss AG, EssilorLuxottica, SynergEyes, Inc., OptiMed Technology, Inc., Aerie Pharmaceuticals, Inc., Eyevance Pharmaceuticals, Ocular Therapeutix, Inc., Visioneering Technologies, Inc., and X-Cel Specialty Contacts

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global therapeutic contact lenses market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global therapeutic contact lenses market

Market Segmentation

• By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Soft Lenses
  • Rigid Lenses
  • Specialty Lenses
• By Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Post-Ocular Surgery
  • Corneal Disorders
  • Drug Delivery
  • Others
• By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
  • Retail Pharmacies
  • Hospitals Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Johnson & Johnson
  • Alcon
  • Bausch + Lomb
  • CooperVision
  • Menicon Co., Ltd.
  • Hoya Corporation
  • Carl Zeiss AG
  • EssilorLuxottica
  • SynergEyes, Inc.
  • OptiMed Technology, Inc.
  • Aerie Pharmaceuticals, Inc.
  • Eyevance Pharmaceuticals
  • Ocular Therapeutix, Inc.
  • Visioneering Technologies, Inc.
  • X-Cel Specialty Contacts

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Therapeutic Contact Lenses Market, By Product Type
  • Global Therapeutic Contact Lenses Market, By Application
  • Global Therapeutic Contact Lenses Market, By Distribution Channel
  • Global Therapeutic Contact Lenses Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Therapeutic Contact Lenses Market, By Product Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Soft Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Rigid Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Specialty Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Therapeutic Contact Lenses Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Post-Ocular Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Corneal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Drug Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Therapeutic Contact Lenses Market, By Distribution Channel, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hospitals Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Therapeutic Contact Lenses Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive landscape

• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alcon
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bausch + Lomb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CooperVision
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Menicon Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hoya Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Carl Zeiss AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EssilorLuxottica
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SynergEyes, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• OptiMed Technology, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aerie Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eyevance Pharmaceuticals
• Ocular Therapeutix, Inc.
• Visioneering Technologies, Inc.
• X-Cel Specialty Contacts

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us